IAS Tukaram Mundhe Transfer Rumours: Maharashtra FDA Commissioner Confirms He Remains in Office, Says Crackdown Will Continue
Maharashtra FDA Commissioner Tukaram Mundhe has denied transfer rumours following his appointment to the MPSC inquiry committee, confirming that his crackdown on unsafe food and substandard medicines will continue.
Mumbai: Senior Maharashtra-cadre IAS officer Tukaram Mundhe has dismissed speculation about his transfer from the state’s Food and Drug Administration (FDA), confirming that he continues to serve as FDA Commissioner. The 2005-batch IAS officer has reiterated that the department’s enforcement drive against unsafe food, adulterated products and spurious or substandard medicines will continue across Maharashtra.
Mundhe issued the clarification through a post on social media platform X on the night of October 12, 2026. The statement came amid speculation that he had been transferred after being appointed secretary of a high-level committee constituted by the Maharashtra government to investigate alleged irregularities in the Maharashtra Public Service Commission (MPSC).
Rejecting the reports, Mundhe made it clear that his appointment to the inquiry committee had not resulted in his removal from the FDA. His clarification also reaffirmed the department’s commitment to enforcing food safety and drug quality standards.
The development comes as the Maharashtra FDA’s intensified inspections and enforcement actions have attracted public attention. While consumers have welcomed efforts to address food adulteration and unsafe products, the department’s actions have also drawn objections from sections of the food and restaurant industry.
What Did IAS Tukaram Mundhe Say About His Transfer?
In his post on X, Mundhe categorically denied reports suggesting that he had been transferred from the Food and Drug Administration. He stated that he remained the Commissioner of FDA Maharashtra and that the department’s campaign against unsafe and substandard products would continue.
He wrote: “No, I have not been transferred from FDA. नाही, माझी FDA मधून बदली झालेली नाही. I continue to serve as Commissioner, FDA Maharashtra. Our fight against unsafe, substandard, adulterated food and spurious, substandard drugs goes on.”
The statement addressed the speculation surrounding his administrative position and confirmed that he continues to hold his existing responsibilities alongside his appointment to the MPSC inquiry committee.
Mundhe’s clarification is significant because his administrative career has frequently attracted attention over transfers and changes in postings. The latest rumours emerged after the state government announced his inclusion in a committee tasked with examining allegations concerning Maharashtra’s public service recruitment system.
By publicly denying the reports, the IAS officer sought to put the immediate speculation to rest. His statement also emphasised continuity in the FDA’s enforcement work against food adulteration, unsafe products and poor-quality medicines.
Transfer Speculation Followed Appointment to MPSC Inquiry Committee
The rumours about Mundhe’s possible transfer emerged after the Maharashtra government appointed him secretary of a five-member inquiry committee to investigate alleged irregularities in the Maharashtra Public Service Commission.
The committee was formed following a prolonged agitation by MPSC aspirants in Pune. The protesting candidates had raised concerns about alleged examination irregularities, including suspected question paper leaks, and demanded greater transparency and accountability in the state’s recruitment system.
The aspirants staged protests for ten consecutive days at S M Joshi Bridge in Pune, pressing the government to address their concerns about the commission’s functioning and the fairness of its examinations.
Following discussions with the protesters, the state government accepted several demands and announced the formation of an inquiry committee. Mundhe’s appointment as secretary placed him in a key administrative role in the investigation.
However, the announcement also triggered speculation that he might leave his position as FDA Commissioner to take up the new responsibility. His October 12 statement clarified that the committee appointment had not resulted in his transfer from the FDA.
Former Judge Dilip Bhosale to Head MPSC Inquiry Committee
The Maharashtra government has constituted a five-member committee to examine alleged irregularities in the MPSC and recommend measures relating to the commission’s functioning.
State minister Shivendraraje Bhosale announced the committee’s formation on Sunday after meeting protesting aspirants at S M Joshi Bridge in Pune. The panel brings together judicial, administrative and police experience to examine the issues raised by the candidates.
The committee will examine allegations relating to MPSC examinations and the functioning of the state recruitment body. Chief Minister Devendra Fadnavis had also indicated that the inquiry would cover the tenure of current and former chairpersons and members of the commission.
The panel’s formation is being viewed as a response to demands from aspirants seeking greater transparency in competitive examinations and recruitment. The inquiry is intended to address concerns surrounding the commission and the processes through which candidates are selected for government positions.
MPSC Aspirants End Their 10-Day Agitation After Government Assurance
The appointment of Mundhe to the inquiry committee was among the developments preceding the withdrawal of the MPSC aspirants’ ten-day agitation in Pune. The candidates had demanded an independent investigation into alleged question paper leaks and recruitment irregularities, along with broader reforms to improve the commission’s functioning.
A state government delegation led by minister Shivendraraje Bhosale met the protesters and informed them that several of their demands had been accepted. One of the principal demands concerned MPSC Chairman Vivek Bhimanwar, whose removal had been sought by the aspirants.
Following discussions, Bhimanwar announced that he would proceed on leave until the inquiry was completed, citing ethical considerations. The protesters subsequently called off their agitation after the government announced the inquiry committee and outlined other measures.
The government also accepted demands concerning the withdrawal of cases against protesters, recruitment to 70,000 posts over three years, and background verification for appointments to senior MPSC positions.
The formation of the committee and Mundhe’s inclusion were among the steps that helped resolve the immediate standoff. The committee’s work will now be important in addressing the allegations and the wider concerns raised by candidates about transparency and accountability in the recruitment process.
IAS Tukaram Mundhe’s FDA Crackdown Draws Public Attention
Although his appointment to the MPSC committee has generated considerable discussion, Mundhe’s work as Maharashtra FDA Commissioner has already placed him in the public spotlight.
Under his leadership, the department has intensified enforcement measures against alleged violations of food safety and drug quality regulations. The FDA has conducted inspections, raids and regulatory actions involving restaurants, eateries and other food businesses suspected of violating prescribed safety and compliance requirements.
The enforcement drive has focused on identifying unsafe, adulterated and substandard food products, while also addressing concerns about spurious and poor-quality medicines. Actions have reportedly included measures against establishments over licensing issues and non-compliance with applicable food safety regulations.
The department’s activities have brought renewed attention to the responsibilities of food businesses to maintain hygiene, ensure product quality and comply with regulatory requirements. Regular inspections and enforcement action are important components of efforts to protect consumers from unsafe products.
Mundhe’s latest statement indicates that these efforts will continue despite his additional assignment as secretary of the MPSC inquiry committee. His clarification signals that he remains in charge of the FDA while also being associated with the panel examining allegations against the state recruitment body.
Consumers Welcome Enforcement, Restaurant Industry Raises Objections
The FDA’s intensified enforcement actions under Mundhe have generated differing reactions among consumers and business operators. Many consumers have welcomed the department’s emphasis on food safety, product quality and accountability, particularly amid concerns about adulteration and unsafe food products.
The inspections have also highlighted the importance of hygiene standards, appropriate licensing and compliance with food safety regulations. For consumers, enforcement against unsafe products is closely linked to public health and confidence in the food supply.
At the same time, the department’s actions have faced resistance from sections of the food and restaurant industry. The available report does not specify the individual objections raised by businesses or provide detailed responses from industry representatives, so the nature and extent of those concerns require further confirmation.
The broader debate reflects the challenge of enforcing food safety requirements while ensuring that businesses understand and comply with the applicable rules. Regulatory action against violations remains a central responsibility of the FDA.
Mundhe Confirms Continuity at Maharashtra FDA
Mundhe’s statement on October 12 has clarified his immediate administrative position amid rumours triggered by his appointment to the MPSC inquiry committee. He has confirmed that he continues to serve as Maharashtra FDA Commissioner and that the department’s action against unsafe food, adulterated products and spurious or substandard medicines will go on.
The MPSC panel, meanwhile, has been established to investigate allegations relating to the state’s public service recruitment system following the ten-day agitation by aspirants in Pune. Mundhe’s role as secretary of the committee is separate from the question of whether he has been transferred from his existing post.
For now, the key development is Mundhe’s explicit denial of the transfer reports. Any subsequent change in his posting would need to be established through an official government order rather than speculation arising from his additional committee assignment.
Editorial note: This article is based on the supplied report and Mundhe’s quoted social media statement. Before publication, verify the official order constituting the MPSC inquiry committee, the names and designations of its members, and the latest FDA posting status. Allegations concerning examination irregularities should be described as allegations unless established by the inquiry or other authoritative findings.
